• Explore /
  • Poster
  • / Enfortumab vedotin treatment regimens and efficacy in urothelial carcinoma: The Mayo Clinic experience.

Enfortumab vedotin treatment regimens and efficacy in urothelial carcinoma: The Mayo Clinic experience.

Abstract Poster

Authors

null

Tara Ballouz

Department of Internal Medicine, Mayo Clinic, Scottsdale, AZ

Tara Ballouz , Nikita Tripathi , Syed Arsalan Ahmed Naqvi , Akshat Saxena , Arifa Bibi , Adam McLain Kase , Daniel S Childs , Jacob Orme , Alan Haruo Bryce , Irbaz Bin Riaz , Parminder Singh

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Urothelial Carcinoma

Track

Urothelial Carcinoma

Sub Track

Therapeutics

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr 627)

DOI

10.1200/JCO.2024.42.4_suppl.627

Abstract #

627

Poster Bd #

H12

Abstract Disclosures

Similar Posters

First Author: Lauren Christine Harshman

First Author: Ioanna Sakellari

First Author: Scott T. Tagawa

First Author: Sarmad Sadeghi